Due to the direct killing effect of T cells on the tumor, the overall survival rate of patients in the group with more CD8+Tex cells was lower, indicating that the depletion of CD8+ T effector was consistent with the poor clinical prognosis of HNSCC patients. The gene discussed is CD8A; the disease is neoplasm.